STROKE trial show a 26% reduction in recurrent stroke with the factor XIa inhibitor asundexian, with no increased bleeding ...

Data validate the efficacy, safety, and tolerability of elismetrep, an investigational first-in-class TRPM8 ...

This approval marks an important new chapter in Merck’s long-standing commitment to research and discovery for people living ...

Detailed price information for Medexus Pharmaceuticals Inc (MDP-T) from The Globe and Mail including charting and trades.

Merck’s Idvynso, a new, two-drug single-tablet regimen of 100 mg doravirine and 0.25 mg islatravir gets US FDA approval for the treatment of HIV-1 infection: Rahway, New Jersey ...

Introduction Reduced exercise performance is common in patients with repaired tetralogy of Fallot (rToF) and relates to ...

Outcomes After Minor Ischemic Stroke in Older Patients Treated With IV Thrombolysis vs Standard of Care in the TEMPO-2 Trial ...

Random rewards and disasters rain down on the island when lucky blocks appear out of nowhere. Image claiming to show Trump's intact ear after assassination attempt is fake. Here's proof Popular weight ...

The Los Angeles Rams don’t just ask their wide receivers to block, but to block a lot. It’s part of their role. It makes me wonder if any rookies would rather not go to L.A. as they’d rather just ...

This study highlights the potential for using deep learning methods on longitudinal health data from both primary and ...

Researchers recently presented data on the secondary endpoints of STEMI-DTU (ST-segment Elevation Myocardial Infarction ...